These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16626893)

  • 1. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
    Wallin AR; Svanvik J; Adell G; Sun XF
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
    Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MAC30 in rectal cancers with or without preoperative radiotherapy.
    Zhang ZY; Zhao ZR; Adell G; Jarlsfelt I; Cui YX; Kayed H; Kleeff J; Wang MW; Sun XF
    Oncology; 2006; 71(3-4):259-65. PubMed ID: 17657172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy.
    Knutsen A; Adell G; Sun XF
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):149-55. PubMed ID: 15337550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy.
    Pachkoria K; Zhang H; Adell G; Jarlsfelt I; Sun XF
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):739-44. PubMed ID: 16199309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.
    Yang L; Zhang H; Zhou ZG; Yan H; Adell G; Sun XF
    Clin Cancer Res; 2011 Jun; 17(11):3760-70. PubMed ID: 21531809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of the phosphatase regenerating liver 3 gene is associated with outcome in patients with colorectal cancer.
    Tamagawa H; Oshima T; Yoshihara K; Watanabe T; Numata M; Yamamoto N; Tuschida K; Shiozawa M; Morinaga S; Akaike M; Masuda M; lmada T
    Hepatogastroenterology; 2012 Oct; 59(119):2122-6. PubMed ID: 22440248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
    Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
    Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
    Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A; Georgiev R; Kurtev P; Kurteva G
    J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
    Eriksen MT; Wibe A; Haffner J; Wiig JN;
    Dis Colon Rectum; 2007 Feb; 50(2):156-67. PubMed ID: 17180256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A; Parvanova V; Georgiev R; Gesheva N
    J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.
    Moparthi SB; Arbman G; Wallin A; Kayed H; Kleeff J; Zentgraf H; Sun XF
    Int J Oncol; 2007 Jan; 30(1):91-5. PubMed ID: 17143516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
    Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
    Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.